z-logo
Premium
Hypoxia‐induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling
Author(s) -
Jones Nicole M.,
Bergeron Marcelle
Publication year - 2004
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2004.02324.x
Subject(s) - neuroprotection , hypoxia (environmental) , mapk/erk pathway , protein kinase b , pi3k/akt/mtor pathway , signal transduction , kinase , biology , phosphorylation , brain damage , endocrinology , microbiology and biotechnology , pharmacology , chemistry , neuroscience , organic chemistry , oxygen
Hypoxic preconditioning (HP) 24 h before hypoxic‐ischemic (HI) injury confers significant neuroprotection in neonatal rat brain. Recent studies have shown that the mitogen‐activated protein kinase (MAPK) and phosphatidylinositol‐3‐kinase (PI3K) intracellular signaling pathways play a role in the induction of tolerance to ischemic injury in heart and brain. To study the role of MAPK (ERK1/2, JNK, p38MAPK) and PI3K/Akt/GSK3β signaling pathways in hypoxia‐induced ischemic tolerance, we examined the brains of newborn rats at different time points after exposure to sublethal hypoxia (8% O 2 for 3 h). Immunoblot analysis showed that HP had no effect on the levels of phosphorylated Akt, GSK3β, JNK and p38MAPK. In contrast, significantly increased levels of phosphorylated ERK1/2 were observed 0.5 h after HP. Double immunofluorescence staining showed that hypoxia‐induced ERK1/2 phosphorylation was found mainly in microvessels throughout the brain and in astrocytes in white matter tracts. Inhibition of hypoxia‐induced ERK1/2 pathway with intracerebral administration of U0126 significantly attenuated the neuroprotection afforded by HP against HI injury. These findings suggest that activation of ERK1/2 signaling may contribute to hypoxia‐induced tolerance in neonatal rat brain in part by preserving vascular and white matter integrity after HI.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here